Trial Details
UNKNOWNBasic Information
| Clinical ID | c552 |
|---|---|
| Identifier | NCT04109300 |
| Trial Title | Preemptive HLA Genotyping for the Safe Use of Infliximab-combination Therapy in Inflammatory Bowel Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases|Ulcerative Colitis|Crohn Disease |
| Interventions | GENETIC: HLADQA1*05A>G screening|OTHER: Standard of Care |
Participant Information
| Sponsor | Western University, Canada |
|---|---|
| City | London |
| Country/Region | Canada |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2020-09-01 |
|---|---|
| Primary Completion Date | 2023-09-01 |
| Completion Date | 2023-09-01 |